Loading clinical trials...
Loading clinical trials...
A Randomized Phase I/II Placebo-controlled Study of Amdoxovir (DAPD) Versus Placebo Together With Enfuvirtide (T-20) Plus Optimized Background Therapy for HIV-Infected Subjects Failing Current Therapy
Conditions
Interventions
Enfuvirtide
Amdoxovir
Locations
9
United States
Univ of Colorado Health Sciences Ctr
Denver, Colorado, United States
Miami University
Miami, Florida, United States
Harvard (Massachusetts General Hosp)
Boston, Massachusetts, United States
Brigham and Womens Hosp
Boston, Massachusetts, United States
Cornell Univ Med Ctr
New York, New York, United States
Columbia Presbyterian Med Ctr
New York, New York, United States
Completion Date
November 1, 2004
Last Updated
November 1, 2021
NCT06627764
NCT06694805
NCT04142047
NCT05398185
NCT07428330
NCT07225530
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions